IL6 and pulmonary fibrosis: For instance, IL-6 blockade using an IL-6-neutralizing antibody in the early or late phase of BLM-induced pulmonary fibrosis resulted in the exacerbation or amelioration of pulmonary fibrosis, respectively [46].